These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35676792)

  • 1. Cytotoxic effect of metformin on butyrate-resistant PMF-K014 colorectal cancer spheroid cells.
    Nittayaboon K; Leetanaporn K; Sangkhathat S; Roytrakul S; Navakanitworakul R
    Biomed Pharmacother; 2022 Jul; 151():113214. PubMed ID: 35676792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C; Liu VW; Chan DW; Yao KM; Ngan HY
    Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Butyrate-Resistant Colorectal Cancer Cell Lines and the Cytotoxicity of Anticancer Drugs against These Cells.
    Nittayaboon K; Leetanaporn K; Sangkhathat S; Roytrakul S; Navakanitworakul R
    Biomed Res Int; 2022; 2022():6565300. PubMed ID: 35909471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Analysis of Butyrate-Resistant Colorectal Cancer-Derived Exosomes Reveals Potential Resistance to Anti-Cancer Drugs.
    Nittayaboon K; Leetanaporn K; Sangkhathat S; Roytrakul S; Navakanitworakul R
    Discov Med; 2024 Jun; 36(185):1306-1315. PubMed ID: 38926117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
    Thent ZC; Zaidun NH; Azmi MF; Senin MI; Haslan H; Salehuddin R
    Curr Drug Targets; 2017; 18(6):734-750. PubMed ID: 27919208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells.
    Klubo-Gwiezdzinska J; Jensen K; Costello J; Patel A; Hoperia V; Bauer A; Burman KD; Wartofsky L; Vasko V
    Endocr Relat Cancer; 2012 Jun; 19(3):447-56. PubMed ID: 22389381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway.
    Zhang P; Zhao S; Lu X; Shi Z; Liu H; Zhu B
    Gene; 2020 Jun; 745():144623. PubMed ID: 32222530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation.
    Sui X; Xu Y; Yang J; Fang Y; Lou H; Han W; Zhang M; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan Q; Pan H; Wang X; He C
    PLoS One; 2014; 9(5):e97781. PubMed ID: 24849329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling.
    Lu CC; Chiang JH; Tsai FJ; Hsu YM; Juan YN; Yang JS; Chiu HY
    Int J Oncol; 2019 Apr; 54(4):1271-1281. PubMed ID: 30720062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms by which low glucose enhances the cytotoxicity of metformin to cancer cells both in vitro and in vivo.
    Zhuang Y; Chan DK; Haugrud AB; Miskimins WK
    PLoS One; 2014; 9(9):e108444. PubMed ID: 25254953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
    IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin Induces Autophagy via Reactive Oxygen Species-Mediated Endoplasmic Reticulum Stress Pathway in Colorectal Cancer Cells.
    Chok KC; Koh RY; Ng MG; Ng PY; Chye SM
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes.
    Saber MM; Al-Mahallawi AM; Nassar NN; Stork B; Shouman SA
    BMC Cancer; 2018 Aug; 18(1):822. PubMed ID: 30111296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaetocochin J, an epipolythiodioxopiperazine alkaloid, induces apoptosis and autophagy in colorectal cancer via AMPK and PI3K/AKT/mTOR pathways.
    Hu S; Yin J; Yan S; Hu P; Huang J; Zhang G; Wang F; Tong Q; Zhang Y
    Bioorg Chem; 2021 Apr; 109():104693. PubMed ID: 33609914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts.
    Leclerc GM; Leclerc GJ; Kuznetsov JN; DeSalvo J; Barredo JC
    PLoS One; 2013; 8(8):e74420. PubMed ID: 24009772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Butyrate-Induced Resistance through AMPK Signaling Pathway in Human Colon Cancer Cells.
    Yoo HY; Park SY; Chang SY; Kim SH
    Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits the development and metastasis of colorectal cancer.
    Sugiura K; Okabayashi K; Seishima R; Ishida T; Shigeta K; Tsuruta M; Hasegawa H; Kitagawa Y
    Med Oncol; 2022 Jul; 39(9):136. PubMed ID: 35780231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.
    O'Brien AJ; Villani LA; Broadfield LA; Houde VP; Galic S; Blandino G; Kemp BE; Tsakiridis T; Muti P; Steinberg GR
    Biochem J; 2015 Jul; 469(2):177-87. PubMed ID: 25940306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.